ResearcherTongji UniversityNo recent work listed
Yukai Xiang
Matched on ORCID iD 0000-0003-3565-8454; OpenAlex author ID A5089269637. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 21
2017: 3 papers · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 2 papers
Papers 8
- Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma. Last author DOI 10.1080/07420528.2021.1890760↗
- Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database. Co-author DOI 10.1155/2021/5573628↗
- The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-019-0828-8↗
- Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. Co-author DOI 10.1155/2018/2360427↗
- High Glucose-Induced ROS Production Stimulates Proliferation of Pancreatic Cancer via Inactivating the JNK Pathway. First author DOI 10.1155/2018/6917206↗
- Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway. Co-author DOI 10.1016/j.bbrc.2017.04.133↗
- Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic can… First author DOI 10.1111/cas.13347↗
- Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expre… Co-author DOI 10.2147/ott.s136840↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dinglai Yu · 5 shared papers, 2017–2021 · strength 0.41
- Paper Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cance… DOI 10.1155/2021/5573628↗
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Mengtao Zhou · 5 shared papers, 2017–2019 · strength 0.38
- Paper The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. DOI 10.1186/s12935-019-0828-8↗
- Paper High Glucose-Induced ROS Production Stimulates Proliferation of Pancreatic Cancer via Inactivating the JNK Pathway. DOI 10.1155/2018/6917206↗
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Chaohao Huang · 4 shared papers, 2017–2021 · strength 0.34
- Paper Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cance… DOI 10.1155/2021/5573628↗
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Bicheng Chen · 4 shared papers, 2017–2018 · strength 0.28
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Paper Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced … DOI 10.2147/ott.s136840↗
- Hongwei Sun · 2 shared papers, 2017–2021 · strength 0.20
- Paper Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cance… DOI 10.1155/2021/5573628↗
- Paper Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activa… DOI 10.1111/cas.13347↗
- Lele Zhang · 1 shared paper, 2021 · strength 0.17
- Bicheng Chen · 2 shared papers, 2018–2019 · strength 0.17
- Keqing Shi · 2 shared papers, 2018–2019 · strength 0.16
- Jie Zhang · 2 shared papers, 2017–2019 · strength 0.16
- Paper The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. DOI 10.1186/s12935-019-0828-8↗
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Bi Lin · 1 shared paper, 2021 · strength 0.13
- Shengjie Dai · 1 shared paper, 2021 · strength 0.13
- Wanqing Weng · 1 shared paper, 2019 · strength 0.09
- Weiguo Huang · 1 shared paper, 2019 · strength 0.09
- Yangyang Guo · 1 shared paper, 2019 · strength 0.09
- Xiandong Zhu · 1 shared paper, 2018 · strength 0.08
- Jiao Min Luo · 1 shared paper, 2018 · strength 0.08
- Fubiao Ni · 1 shared paper, 2018 · strength 0.08
- Li Ding · 1 shared paper, 2018 · strength 0.08
- Jie Zhang · 1 shared paper, 2018 · strength 0.07
- Xince Huang · 1 shared paper, 2017 · strength 0.07
- Zhengde Wen · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.